This site uses cookies, including third-party cookies, that help us to provide and improve our services.

Privacy Policy
- Global Locations -
Headquarters
Future Market Insights, Inc.
Christiana Corporate, 200 Continental Drive, Suite 401, Newark, Delaware - 19713, United States
T: +1-845-579-5705
MEA
Market Access DMCC
1602-6 Jumeirah Bay X2 Tower, Plot No: JLT-PH2-X2A,
Jumeirah Lakes Towers, Dubai,
United Arab Emirates
Americas
Future Market Insights
616 Corporate Way, Suite 2-9018,
Valley Cottage, NY 10989,
United States
T: +1-347-918-3531
Europe
Future Market Insights
3rd Floor, 207 Regent Street,
London W1B 3HH
United Kingdom
T: + 44 (0) 20 8123 9659
D: +44 (0) 20 3287 4268
APAC
Future Market Insights
Office No. 401-A, 4th Floor,
VANTAGE 9, S.No. 36/1/1,
Baner, Pune 411045 India

Plasma-derived Protein Therapies Market

Market Insights on Plasma-derived Protein Therapies covering sales outlook, demand forecast & up-to-date key trends

Plasma-derived Protein Therapies Market : Global Industry Analysis 2015 - 2019 and Opportunity Assessment 2020 - 2030

Plasma-derived Protein Therapies Market Overview

Plasma-derived therapies allow individuals with chronic and life threatening diseases to lead more productive and healthy lives by replacing the missing or deficient proteins. The patients relying on these therapies require regular injections or infusions throughout their lives.

Since the diseases treated by plasma therapies affect a small percentage of the population, they are often considered as rare.  Most of these diseases are genetic and chronic conditions. However, over the years there is a rise in these rare diseases demanding more treatment options.

There have been initiatives to create awareness about the plasma-derived protein therapies and its importance. For instance, CSL Behring and Plasma Protein Therapeutics Association (PPTA's) other global member companies, In 2018, the PPTA launched a video campaign and called it as “How Is Your Day?”.

The objectives of the campaign were to differentiate traditional from the plasma-derived protein therapies and to highlight the value plasma-derived protein therapies provide to individuals with rare and serious conditions. These initiatives are further expected to boost the growth of the plasma-derived protein therapies market.

Plasma-derived Protein Therapies Market: Drivers and Restraints

Higher volume of immunoglobulin usage in developed countries and strong demand for albumin in Asia pacific is expected to drive the growth of the plasma-derived protein therapies market during the forecast period. Increasing focus and growing investment in innovation is anticipated to propel the growth of the plasma-derived protein therapies market.

For Instance, in March 2016, Grifols announced an investment of US$ 360 Mn to expand its capabilities in the production of plasma-derived therapies. The investment will increase the purification and plasma fractionation capacity of several proteins. Thus leading the plasma-derived protein therapies market towards a significant growth.

In addition, rising incidence of life threatening diseases such as multifocal motor neuropathy (MMN), ideopathic thrombocytopenic purpura (ITP) and other infectious diseases including rabies tetanus, hepatitis A&B, and varicella is also expected to drive the growth of the market.

According to WHO estimates that in 2015, around 257 million were living with chronic hepatitis B infection.However, high cost of these therapies may restrict the growth of the plasma-derived protein therapies market. Moreover, stringent regulations and reimbursement scenario may hamper the plasma-derived protein therapies market during the forecast period.

Customize this Report

Let us know your requirement to get
100% FREE customization

Plasma-derived Protein Therapies Market: Overview

Based on type, the immunoglobulin segment is expected to account for the largest share due to its beneficial application in treating patients with rare diseases. Additionally, Albumin is also expected to lead considerable growth in this segment owing to its demand in developing countries.

In the application segment, the immunological disorders are expected to hold the highest share due to growing awareness about treatment options provided by plasma-derived therapies. Based on end user, the hospital segment is expected to have the largest share due to frequent patient visits for diagnosis and treatment of various infectious and immunological disorders.

Plasma-derived Protein Therapies Market: Regional-Wise Outlook

Geographically, the Plasma-derived protein therapies market is segmented into seven regions, i.e.; Latin America, South Asia, Oceania, East Asia, Europe, North America and Middle East & Africa.

The North America is expected to account for the largest share in the Plasma-derived protein therapies market due to rising geriatric population who are more susceptible to life threatening diseases. According to the U.S Census Bureau, there were 40.3 million U.S. residents 65 years and older in the 2010 census and more than 54 million on July 1, 2019.

Other factors contributing towards the growth of the regional growth of the market in North America is large patient base and well- developed healthcare infrastructure.Asia Pacific is expected to experience fastest growth in the plasma-derived protein therapies market. Increasing demand for advanced treatment option and rise in per capita expenditure are predicted to drive the growth of the market in this region.

Additionally, the increasing focus in the development of healthcare infrastructure in the developing countries is also anticipated to drive the growth of the plasma-derived protein therapies market in Asia Pacific during the forecast period.

Sabyasachi Ghosh
Principal Consultant
LinkedIn
Talk to Analyst

Find your sweet spots for generating winning opportunities in this market.

Talk to Analyst

Plasma-derived Protein Therapies Market: Key players

Some of the players identified in the Plasma-derived protein therapies market include:

  • CSL Behring LLC
  • Octapharma AG
  • Biotest AG
  • Kedrion S.P.A
  • Bayer AG
  • Grifols S.A.

The report is a compilation of first-hand information, qualitative and quantitative assessment by industry analysts, inputs from industry experts and industry participants across the value chain.

The report provides in-depth analysis of parent market trends, macro-economic indicators and governing factors along with market attractiveness as per segments. The report also maps the qualitative impact of various market factors on market segments and geographies.

  • Market Segments
  • Market Dynamics
  • Market Size
  • Supply & Demand
  • Current Trends/Issues/Challenges
  • Competition & Companies involved
  • Technology Matrix
  • Value Chain

Regional analysis of the Plasma-derived protein therapies market report includes

  • North America
  • Latin America
  • Europe
  • South  Asia
  • East Asia
  • Oceania
  • Middle East and Africa
Become a MarketNgage Insider

An unified Market Research Subscription Platform, built for today’s disparate research needs.

Plasma-derived Protein Therapies Market: Segmentation

Tentatively, the global Plasma-derived protein therapies market has been segmented on the basis of type, route of administration, application and end user.

Based on Type :

  • Coagulation factors
  • Immunoglobulins
  • Hyperimmune globulins
  • Albumin
  • C1-esterase inhibitor (C1-INH)
  • Alpha-1 Proteinase Inhibitors

Based on Route of Administration :

  • Intravenous
  • Subcutaneous

Based on Application :

  • Immunological disorders
  • Infectious disorders
  • Coagulation and bleeding disorders
  • Metabolic disorders

Based on End-user  :

  • Hospitals
  • Research institutes
  • Ambulatory surgical care centers

Table of Content

NA

Customize this Report

Let us know your requirement to get
100% FREE customization

List of Tables

NA

Sabyasachi Ghosh
Principal Consultant
LinkedIn
Talk to Analyst

Find your sweet spots for generating winning opportunities in this market.

Talk to Analyst

List of Charts

NA

Need specific information?

Request Customization

Explore Healthcare Insights

View Reports
Google translate

Plasma-derived Protein Therapies Market